Effect on Posterior capsule opacification of topical diclofenac sodium vs dexamethasone phosphate after cataract surgery

The effect on posterior capsule opacification of treatment with diclofenac vs dexamethasome after uncomplicated cataract surgery was compared. A prospective, randomized double-masked trial randomly assigned patients to receive either 0.1% diclofenac sodium or 0.1% dexamethasone phosphate eyedrops 4 weeks postoperatively. Posterior capsule opacification was evaluated after 2 years. Diclofenac-treated eyes had a lower extent and degree of posterior capsule opacification, although the difference was statistically insggnificant. Presented in part at the American Academy of Ophthalmology annual Meeting. Orlando, Fla., October 26, 1999. The authors have stated that they do not have a significant financial interest or other relationship with amy product manufacturer or provider of services discussed in this article.